Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases

Cancer Research

Volumn 63, Issue 14, 2003, Pages 3886-3890

  Abate Shen, Cory ^a,b,c,e   Banach Petrosky, Whitney A ^a,b   Sun, Xiaohui ^a,b   Economides, Kyriakos D ^a,b   Desai, Nishita ^a,b   Gregg, Jeffery P ^d   Borowsky, Alexander D ^d   Cardiff, Robert D ^d   Shen, Michael M ^a,b,c,e  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CABM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; HOMEOBOX; LYMPH NODE METASTASIS; MALE; MOUSE; NKX3.1 GENE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PTEN GENE; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ANIMALS; DISEASE MODELS, ANIMAL; HOMEODOMAIN PROTEINS; HUMANS; LYMPHATIC METASTASIS; MALE; MICE; MICE, INBRED C57BL; MICE, NUDE; MUTATION; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; ORCHIECTOMY; PHOSPHORIC MONOESTER HYDROLASES; PROSTATIC NEOPLASMS; PTEN PHOSPHOHYDROLASE; RATS; TESTOSTERONE; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0043244937     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. DeMarzo, A., Nelson, W. G., Isaacs, W. G., and Epstein, J. I. Pathology and molecular aspects of prostate cancer. Lancet, 361: 955-964, 2003,
2. Isaacs, W., De Marzo, A., and Nelson, W. G. Focus on prostate cancer. Cancer Cell, 2: 113-116, 2002.
3. Abate-Shen, C., and Shen, M. M. Molecular genetics of prostate cancer. Genes Dev., 14: 2410-2434, 2000.
4. Abate-Shen, C., and Shen, M. M. Mouse models of prostate carcinogenesis. Trends Genet., 18: S1-S5, 2002.
5. Dong, J. T. Chromosomal deletions and tumor suppressor genes in prostate cancer. Cancer Metastasis Rev., 20: 173-193, 2001.
6. Voeller, H. J., Augustus, M., Madike, V., Bova, G. S., Carter, K. C., and Gelmann, E. P. Coding region of NKX3.1, a prostate-specific homeobox gene on 8p21, is not mutated in human prostate cancers. Cancer Res., 57: 4455-4459, 1997.
7. Bowen, C., Bubendorf, L., Voeller, H. J., Slack, R., Willi, N., Sauter, G., Gasser, T. C., Koivisto, P., Lack, E. E., Kononen, J., Kallioniemi, O. P., and Gelmann, E. P. Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression. Cancer Res., 60: 6111-6115, 2000.
8. Bhatia-Gaur, R., Donjacour, A. A., Sciavolino, P. J., Kim, M., Desai, N., Young, P., Norton, C. R., Gridley, T., Cardiff, R. D., Cunha, G. R., Abate-Shen, C., and Shen, M. M. Roles for Nkx3.1 in prostate development and cancer. Genes Dev., 13: 966-977, 1999.
9. Kim, M. J., Bhatia-Gaur, R., Banach-Petrosky, W. A., Desai, N., Wang, Y., Hayward, S. W., Cunha, G. R., Cardiff, R. D., Shen, M. M., and Abate-Shen, C. Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis. Cancer Res., 62: 2999-3004, 2002.
10. Kim, M. J., Cardiff, R. D., Desai, N., Banach-Petrosky, W. A., Parsons, R., Shen, M. M., and Abate-Shen, C. Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis. Proc. Natl. Acad. Sci. USA. 99: 2884-2889, 2002.
11. McMenamin, M. E., Soung, P., Perera, S., Kaplan, I., Loda, M., and Sellers, W. R. Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. Cancer Res., 59: 4291-4296, 1999.
12. Di Cristofano, A., and Pandolfi, P. P. The multiple roles of PTEN in tumor suppression. Cell, 100: 387-390, 2000.
13. Vivanco, I., and Sawyers, C. L. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat. Rev. Cancer, 2: 489-501, 2002.
14. Di Cristofano, A., De Acetis, M., Koff, A., Cordon-Cardo, C., and Pandolfi, P. P. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nat. Genet., 27: 222-224, 2001.
15. Podsypanina, K., Ellenson, L. H., Nemes, A., Gu, J., Tamura, M., Yamada, K. M., Cordon-Cardo, C., Catoretti, G., Fisher, P. E., and Parsons, R. Mutation of Pten/ Mmac1 in mice causes neoplasia in multiple organ systems. Proc. Natl. Acad. Sci. USA, 96: 1563-1568, 1999.
16. Park, J. H., Walls, J. E., Galvez, J. J., Kim, M., Abate-Shen, C., Shen, M. M., and Cardiff, R. D. Prostatic intraepithelial neoplasia in genetically engineered mice. Am. J. Pathol., 161: 727-735, 2002.
17. Gelmann, E. P. Molecular biology of the androgen receptor. J. Clin. Oncol., 20: 3001-3015, 2002.
18. Li, P., Nicosia, S. V., and Bai, W. Antagonism between PTEN/MMACI/TEP-1 and androgen receptor in growth and apoptosis of prostatic cancer cells. J. Biol. Chem., 276: 20444-20450, 2001.
19. Gingrich, J. R., Barrios, R. J., Morton, R. A., Boyce, B. F., DeMayo, F. J., Finegold, M. J., Angelopoulou, R., Rosen, J. M., and Greenberg, N. M. Metastatic prostate cancer in a transgenic mouse. Cancer Res., 56: 4096-4102, 1996.
20. Gingrich, J. R., Barrios, R. J., Kattan, M. W., Nahm, H. S., Finegold, M. J., and Greenberg, N. M. Androgen-independent prostate cancer progression in the TRAMP model. Cancer Res., 57: 4687-4691, 1997.
21. Masumori, N., Thomas, T. Z., Chaurand, P., Case, T., Paul, M., Kasper, S., Caprioli, R. M., Tsukamoto, T., Shappell, S. B., and Matusik, R. J. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential. Cancer Res., 61: 2239-2249, 2001.
22. Kaplan-Lefko, P. J., Chen, T. M., Ittmann, M. M., Barrios, R. J., Ayala, G. E., Huss, W. J., Maddison, L. A., Foster, B. A., and Greenberg, N. M. Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model. Prostate, 55: 219-237, 2003.